Table 1.
Baseline characteristics of patients with cardiac amyloidosis.
| Male, n (%) | 33 (75) |
| Female, n (%) | 11 (25) |
| Age [years] | 73.7 ± 8.9 |
| BMI [kg/m2] | 25.2 ± 3.5 |
| Body surface [m2] | 1.9± 0.2 |
| Arterial hypertension, n (%) | 34 (77.3) |
| Systolic BP [mmHg] | 119.6 ± 20.9 |
| Diastolic BP [mmHg] | 74.3 ± 14.1 |
| Heart rate [min] | 72.5 ± 10.7 |
| Left ventricular EF [%] | 46.4 ± 9.6 |
| NYHA level | |
| NYHA I, n (%) | 0 (0) |
| NYHA II, n (%) | 6 (13.6) |
| NYHA III, n (%) | 36 (81.1) |
| NYHA IV, n (%) | 2 (4.5) |
| NTproBNP [pg/mL] | 3310 ± 897.3 |
| Coronary artery disease, n (%) | 14 (31.8) |
| Atrial fibrillation, n (%) | 17 (38.6) |
| CHA2DS2-VASC Score | 4 {3;5} |
| COPD, n (%) | 3 (6.8) |
| Diabetes mellitus, n (%) | 1 (2.3) |
| Stroke, n (%) | 5 (11.4) |
BMI: body mass index; BP: blood pressure; COPD: chronic obstructive pulmonary disease; EF: ejection fraction; NYHA: New York Heart Association; NTproBNP: brain natriuretic peptide.